Histiocytic Disorders

2

Review clinical trials related to Histiocytic Disorders. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.

Participants needed: 99,999
Trial details
Biological sex: AllType: ObservationalSponsor: Center for International Blood and Marrow Transplant ResearchUpdated: Jun 4, 2026Locations: 142
Eligibility criteria

Disorders affecting the hematopoietic system that are inherited, acquired, or re... [+2]

Patients who are receiving only licensed CBUs [+3]

Status: Recruiting

Mirdametinib in Histiocytic Disorders

The purpose of this study is to see if treatment with mirdametinib in patients with Langerhans cell histiocytosis (LCH) or other histiocytic disorders will be better than current treatments and with fewer side effects.

Participants needed: 40
Trial details
Phase: Phase 2Age: 2+Biological sex: AllType: InterventionalSponsor: Children's Hospital Medical Center, CincinnatiUpdated: Sep 16, 2025Locations: 1
Eligibility criteria

Subjects must be ≥ 2 years of age AND have a diagnosis of a histiocytic disorder... [+8]

Myelosuppressive Chemotherapy: Must not have received any cytotoxic chemotherapy... [+11]